Insiders Altimmune, Inc.

Equities

ALT

US02155H2004

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:00 2025-07-18 EDT			5-day change	1st Jan Change
4.080 ^USD	+0.74%		-1.45%	-43.41%

07-09	Altimmune, Inc. Announces Initiation of Restore Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol-Associated Liver Disease	CI
06-30	Altimmune, Inc.(NasdaqGM:ALT) dropped from Russell 3000E Value Index	CI

Insiders

Altimmune, Inc. Announces Retirement of Scott Harris as Chief Medical Officer, Effective February 28, 2026	02-27	CI
Altimmune, Inc. Announces Board Appointments	02-25	CI
Altimmune Names Greg Weaver Chief Financial Officer	11-11	MT
Altimmune, Inc. Announces That David J. Drutz Will Not Stand for Re-Election to the Board	24-08-15	CI
Altimmune CFO Richard Eisenstadt Dies	24-06-26	MT
Altimmune, Inc. Appoints Andrew Shutterly as Principal Financial Officer and Principal Accounting Officer	24-06-26	CI
Altimmune, Inc. Appoints Catherine Angell Sohn, Pharm.D. to Its Board of Directors	23-03-27	CI
Altimmune, Inc. Appoints Raymond Jordt as Chief Business Officer	23-01-04	CI
Insider Sell: Altimmune	22-12-22	MT
Insider Sell: Altimmune	22-09-01	MT
Insider Sell: Altimmune	22-07-05	MT
Insider Sell: Altimmune	22-06-28	MT
Altimmune, Inc. Announces Management Changes	21-12-13	CI
Altimmune Names Richard Eisenstadt as Next CFO	21-12-13	MT
ObsEva Names Will Brown Chief Financial Officer	21-12-13	MT
ObsEva to Appoint Altimmune CFO to Same Position	21-12-13	MT
Insider Trends: Altimmune Insider Disposition Interrupting 90-Day Buy Trend	20-12-02	MT
Insider Trends: 90-Day Insider Buying Trend at Altimmune Interrupted with Disposition of Shares	20-11-13	MT
Insider Trends: Insider Disposition at Altimmune Scaling Back 90-Days of Buying	20-11-13	MT
Altimmune, Inc. Announces Board Changes	20-07-16	CI
Altimmune, Inc. Appoints Diane Jorkasky to Its Board of Directors	20-05-12	CI
Altimmune, Inc. Appoints M. Scott Harris as Chief Medical Officer	19-09-09	CI
Altimmune, Inc. Announces Resignation of Sybil Tasker as Chief Medical Officer, Effective June 30, 2019	19-06-07	CI
Altimmune, Inc. Announces Executive Changes	18-11-27	CI
Altimmune, Inc. Announces Management Changes	18-10-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Altimmune, Inc.

Equities

ALT

US02155H2004

Biotechnology & Medical Research

Insiders

Filters